Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01446146|
Recruitment Status : Completed
First Posted : October 5, 2011
Last Update Posted : July 24, 2013
|Condition or disease||Intervention/treatment||Phase|
|Posttraumatic Stress Disorder (PTSD)||Behavioral: Informed decision making Behavioral: Placebo session||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||27 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||January 2013|
|Actual Study Completion Date :||January 2013|
Experimental: IDM intervention
Will receive a 40 minute intervention session with a clinician, learning about PTSD treatment options and choosing a preferred treatment.
Behavioral: Informed decision making
40 minute session with a clinician. Participants will learn about the available PTSD treatment options and will be given a decision aid with more information.
Placebo Comparator: Treatment as usual plus placebo session
Will work with provider to select a treatment plan and will receive a 40 minute session without IDM intervention.
Behavioral: Placebo session
Participant will complete clinician-administered measures in a 40-minute session.
- Treatment participation [ Time Frame: 4 months ]Trauma Recovery Program service utilization as assessed by chart review.
- Treatment satisfaction [ Time Frame: 4 months ]Assessed via self-report measures (Client Satisfaction Questionnaire, Credibility/Expectancy Questionnaire) and semi-structured interview
- Change in PTSD severity [ Time Frame: Baseline and 4 months ]Assessed by the PCL-M at baseline and 4 month follow-up
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01446146
|United States, Texas|
|Michael E. DeBakey VA Medical Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Juliette M Mott, PhD||MDVAMC, BCM, SC MIRECC|